Please login to the form below

Not currently logged in
Email:
Password:

Tudor Reilly achieves PRCA standard

Tudor Reilly has achieved the Public Relations Consultancy Association's consultancy management standard, a quality certification for PR firms

Tudor Reilly has achieved the Public Relations Consultancy Association's (PRCA) consultancy management standard (CMS), a quality certification for firms working in the public relations industry.

The CMS is an independently audited set of eight tests covering strict quality standards in management communication and service delivery. It combines elements of ISO 9000, a set of management standards produced by the International Organization for Standardization, and Investors in People, a tool to improve business performance through its employees currently administered by UK Commission for Employment and Skills.

Criteria for the CMS awarded by the PRCA is specific to the public relations industry.

Julie Walters, managing director, Tudor Reilly said: "We are thrilled to have passed this prestigious standard on our first attempt. The result reflects the high standards we've set ourselves and we very much appreciate the external recognition."

Francis Ingham, chief executive, PRCA said: "The consultancy management standard was developed specifically to ensure that PRCA members have the systems and structures in place to meet and exceed clients' expectations. The standard has been so successful that it has now been adopted in 11 countries around the world."

Tudor Reilly is one of over 200 PRCA members based in the UK. The consultancies are of all sizes, working for clients in all business sectors, with a total of around 5,000 employees.

22nd February 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...

Infographics